Current effectiveness of Helicobacter pylori eradication treatment in primary care setting in Korea.
- Author:
Jeong Hoon LEE
1
;
Hwi Young KIM
;
Joo Kyung PARK
;
Joo Hyun SHIM
;
Ji Won KIM
;
Jin Hyok HWANG
;
Byeong Gwan KIM
;
Dong Kyung CHANG
;
Jin Wook KIM
;
Na Young KIM
;
Dong Ho LEE
;
Hyun Chae JUNG
;
Yong Bum YOON
;
In Sung SONG
Author Information
1. Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea. dhljohn@yahoo.co.kr
- Publication Type:Original Article
- Keywords:
Helicobacer pylori;
Drug therapy;
Primary care
- MeSH:
Biopsy;
Breath Tests;
Diagnosis;
Drug Therapy;
Duodenal Ulcer;
Female;
Gastritis;
Gastroscopy;
Helicobacter pylori*;
Helicobacter*;
Humans;
Korea*;
Male;
Peptic Ulcer;
Primary Health Care*;
Rabeprazole;
Seoul;
Stomach Ulcer;
Urea
- From:Korean Journal of Medicine
2003;65(4):422-425
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Since the international guideline of Helicobacter pylori eradication therapy was introduced into Korea, many reports about eradication outcomes have been documented. These data were published mostly from referred university hospital. However, in Korea, majority of patients has been treated with H.pylori eradication regimen in primary care setting. This study was performed to investigate the eradication rate of H. pylori in primary care office of Seoul, Korea. METHODS: Total 173 patients with H.pylori-positive gastroscopy results received eradication regimen-mainly one week PPI based triple therapy-from January 1998 to March 2003. Four weeks after completion of medication, urea breath test, biopsy and CLO test were performed to detect H.pylori. RESULTS: Total eradication rate was 87.9%. The eradication rate of male and female were 90.3% and 84.3%, respectively (p>0.05). The eradication rate of patients older than younger than 60 was 81.5% vs 89.0%, respectively (p>0.05). There was no statistical significance in annual eradication rate. In eradication rate, there was no significant difference among PPI regimen (omeprazole, rabeprazole, pantoprazole). Whether endoscopic diagnosis is gastric ulcer or duodenal ulcer, there was no statistical difference in eradication rate between them. In the same way, there was also no statistical difference between peptic ulcer and H.pylori associated gastritis. CONCLUSION: The current eradication rate of H. pylori in primary care setting of Korea was 87.9%. H.pylori eradication rate in primary care setting was not much different from that in referred hospital in Korea, but it was lower than that reported by controlled trials of 1995 (initial times of introduction of international guide line into Korea). So far, the results have been acceptable, but there still remains to be investigated in PPI-based triple therapy as H.pylori eradication in primary care setting in the future of Korea.
